RA Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.66M Sell
932,973
-34,027
-4% -$170K 0.08% 57
2025
Q1
$7.75M Hold
967,000
0.13% 68
2024
Q4
$7.18M Hold
967,000
0.1% 80
2024
Q3
$9.19M Buy
+967,000
New +$9.19M 0.11% 68